Cite

HARVARD Citation

    Seatla, K. et al. (2018). Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana. AIDS. p. . [Online]. 
  
Back to record